Biopharma News

Feb 21, 2018
By BioPharm International Editors
The companies have partnered to develop and commercialize vectorized antibodies against tau for Alzheimer's and other neurodegenerative diseases.
Feb 15, 2018
By BioPharm International Editors
Fluarix Tetra has been approved for use in children aged six months and above.
Feb 14, 2018
By BioPharm International Editors
Ferring Pharmaceuticals will expand its biologics capabilities at its headquarters and manufacturing site in Saint-Prex, Switzerland.
Feb 14, 2018
By BioPharm International Editors
The companies will work together on developing regenerative medicine therapies for heart failure.
Feb 09, 2018
By BioPharm International Editors
The acquisition strengthens an already existing collaboration between the companies to advance clinical development of therapies across multiple drug categories.
Feb 07, 2018
By BioPharm International Editors
Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.
Feb 06, 2018
By BioPharm International Editors
Amgen plans to invest approximately $300 million in a new biomanufacturing plant in the United States.
Feb 06, 2018
By BioPharm International Editors
Paratek has completed submission of two new drug applications for oral and intravenous omadacycline, a new antibiotic for pneumonia and skin infections.
Feb 02, 2018
By BioPharm International Editors
Shire will receive exclusive license to develop and commercialize AB Biosciences' pan receptor interacting molecule program for autoimmune and inflammatory diseases.
Jan 30, 2018
By BioPharm International Editors
A manufacturing disruption has led to an EpiPen shortage in Canada, which currently has no alternative auto-injectors available on the market.
native1_300x100
lorem ipsum